Vanberra Signal
Free trial

PD Neurotechnology

Curated by Signal

Developer of a wearable device for Parkinson's patients

Health Technologypdneurotechnology.com

Overview

Developer of a wearable device for Parkinson's patients. It offers a smart wearable device for monitoring the movement disorders of Parkinson's disease. It is a home-based wearable device that is used to collect kinematic data and monitor the symptoms of Parkinson's diseases such as motor symptoms and movement disorders. The data is tracked by a cloud platform that enables the physician to analyze, track the progress, and provide a personalized disease treatment regimen.

Key facts

Founded
2015
Headquarters
London, United Kingdom
Stage
Sign up to view
Industry
Health Technology

Business model

3 products and services
Sign up to view

Contact

Primary office
Sign up to view
Email
Sign up to view
Phone
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • Motion

    Platform offering marketing solutions for care homes

    Health TechnologyChapeltown, United Kingdom

  • MedPoint

    Provider of prescription collecting machine for pharmacists

    Health TechnologyKirkcaldy, United Kingdom

  • Abtrace

    AI-based EHR management tools for supporting doctor's decision making

    Health TechnologyLondon, United Kingdom

About PD Neurotechnology

What does PD Neurotechnology do?

Developer of a wearable device for Parkinson's patients.

Where is PD Neurotechnology headquartered?

PD Neurotechnology is headquartered in London, United Kingdom.

When was PD Neurotechnology founded?

PD Neurotechnology was founded in 2015.

Which sector is PD Neurotechnology in?

PD Neurotechnology operates in Health Technology.

Who are PD Neurotechnology's competitors?

Companies similar to PD Neurotechnology include Motion, MedPoint, and Abtrace.